The proportion of patients achieving HbA1c < 7% target was 13.7%, the proportion of patients who were poorly controlled (HbA1c > 8%) decreased from 62.1% at baseline to 33.1% at 3 months, 62.3% of patients showed simultaneous reductions in HbA1c and body weight.